Investment in E.P. Medical Inc.
- Author: admin_epmed
- Category: NEWS
MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., has underwritten a Series A1 investment in E.P. Medical Co., Ltd. (Representative Director: Yuji Matsumaru; Address: 3-11-5 Nihonbashi-Honcho, Chuo-ku, Tokyo), a company developing a transcutaneous transvascular electroencephalography device to identify focal location in intractable epilepsy.
Details are attachedThis PDF (external link)Please check.
Related posts
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our Endovascular EEG device (EP-01).
We are pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our…
- Category: NEWS
Regarding our company name change
As of December 13, 2023, our company name has changed from E.P.Medical Inc. to Epsilon Medical Inc. We appreciate your…
- Category: NEWS
A specific clinical study at the University of Tsukuba has been published on jRCT
Following deliberation by the Clinical Research Review Committee of the University of Tsukuba, information on specific clinical research on our…
- Category: NEWS
Certified as a venture company originating from the University of Tsukuba
Our company has been certified as a venture company spun out of the University of Tsukuba. University of Tsukuba
- Category: NEWS